CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+29.24%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.46B
AUM Growth
+$433M
(+4.8%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
907
New
103
Increased
255
Reduced
393
Closed
103
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$59.9M |
| 2 |
Merck
MRK
|
$49.9M |
| 3 |
Danaher
DHR
|
$49.5M |
| 4 |
JD.com
JD
|
$44.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
$40.8M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$114M |
| 2 |
Alibaba
BABA
|
$102M |
| 3 |
Salesforce
CRM
|
$58.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$58.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$52M |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.98% |
| 3 | Consumer Discretionary | 8.92% |
| 4 | Financials | 8.6% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Toronto Dominion Bank
TD
$127B
| $5.59M | 0.06% |
125,740
-50,611
| -29% | -$2.25M |
|
302
Ormat Technologies
ORA
$5.51B
| $5.59M | 0.06% |
+88,052
| New | +$5.59M |
|
303
Cardinal Health
CAH
$35.7B
| $5.59M | 0.06% |
107,098
+68,724
| +179% | +$3.59M |
|
304
Blackrock
BLK
$170B
| $5.55M | 0.06% |
10,195
-550
| -5% | -$299K |
|
305
Arcus Biosciences
RCUS
$1.3B
| $5.52M | 0.06% |
+222,942
| New | +$5.52M |
|
306
Roper Technologies
ROP
$55.8B
| $5.5M | 0.06% |
14,174
-2,418
| -15% | -$939K |
|
307
Jones Lang LaSalle
JLL
$14.8B
| $5.47M | 0.06% |
52,883
-41,764
| -44% | -$4.32M |
|
308
Pfizer
PFE
$141B
| $5.46M | 0.06% |
175,984
-360,314
| -67% | -$11.2M |
|
309
Veracyte
VCYT
$2.55B
| $5.41M | 0.06% |
209,015
+45,591
| +28% | +$1.18M |
|
310
Akamai
AKAM
$11.3B
| $5.36M | 0.06% |
50,014
-19,887
| -28% | -$2.13M |
|
311
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.51B
| $5.36M | 0.06% |
188,152
+93,690
| +99% | +$2.67M |
|
|
TCDA
312
DELISTED
Tricida, Inc. Common Stock
TCDA
| $5.26M | 0.06% |
191,500
+7,500
| +4% | +$206K |
|
313
Restaurant Brands International
QSR
$20.7B
| $5.17M | 0.05% |
95,364
+90,254
| +1,766% | +$4.9M |
|
314
Marsh & McLennan
MMC
$100B
| $5.17M | 0.05% |
48,108
-8,003
| -14% | -$859K |
|
315
Syndax Pharmaceuticals
SNDX
$1.47B
| $5.15M | 0.05% |
+347,458
| New | +$5.15M |
|
|
CETV
316
DELISTED
Central European Media Enterprises Ltd
CETV
| $5.13M | 0.05% |
1,450,357
-1,017,644
| -41% | -$3.6M |
|
317
Baker Hughes
BKR
$44.9B
| $5.12M | 0.05% |
332,726
-25,968
| -7% | -$400K |
|
318
Parker-Hannifin
PH
$96.1B
| $5.12M | 0.05% |
27,916
-10,576
| -27% | -$1.94M |
|
319
Boston Properties
BXP
$12.2B
| $5.11M | 0.05% |
56,499
+41,165
| +268% | +$3.72M |
|
|
SAGE
320
DELISTED
Sage Therapeutics
SAGE
| – | – |
-149,300
| Closed | -$10.5M |
|
321
Aprea Therapeutics
APRE
$9.03M
| $5.07M | 0.05% |
+6,539
| New | +$5.07M |
|
322
United Rentals
URI
$62.7B
| $5.01M | 0.05% |
33,598
+26,234
| +356% | +$3.91M |
|
323
Genmab
GMAB
$16.9B
| $4.96M | 0.05% |
146,430
-46,432
| -24% | -$1.57M |
|
324
Freeport-McMoran
FCX
$66.5B
| $4.96M | 0.05% |
+428,258
| New | +$4.96M |
|
325
Dominion Energy
D
$49.7B
| $4.93M | 0.05% |
+60,777
| New | +$4.93M |
|